Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
Jul 31, 2012

Top Paid Women in Biopharma

GEN’s listing of the 25 highest-paid females in the industry.

Top Paid Women in Biopharma

These 25 women are pulling in the big bucks. [© stefa_neve - Fotolia.com]

  • #10. Robin Smith

    CEO, NeoStem

    2011 Compensation: $3,647,772

  • #9. Robin L. Washington

    SVP and CFO, Gilead Sciences

    2011 Compensation: $4,032,193

  • #8. Silvia Ayyoubi

    Head of Human Resources, Roche

    2011 Compensation: $4,035,692

  • #7. Sandra Leung

    General Counsel and Secretary, Bristol-Myers Squibb

    2011 Compensation: $5,491,673

  • #6. Laura J. Schumacher

    EVP, General Counsel and Secretary, Abbott Laboratories

    2011 Compensation: $5,567,493

  • #5. Amy W. Schulman

    EVP, General Counsel, President and GM, Nutrition, Pfizer

    2011 Compensation: $5,764,662

  • #4. Beatrice Cazala

    EVP Commercial Operations, Bristol-Myers Squibb

    2011 Compensation: $5,941,167

  • #3. Naomi Kelman

    Head of Novartis OTC Division, Novartis1

    2011 Compensation: $6,927,529

  • #2. Sherilyn S. McCoy

    Vice Chairman, Executive Committee, Johnson & Johnson

    2011 Compensation: $8,733,678

  • #1. Heather Bresch

    CEO, Mylan

    2011 Compensation: $9,640,486


    Leave a comment by clicking the “Comments” icon below. We want to hear your thoughts!


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »